Literature DB >> 7383953

Rifampicin-induced thrombocytopenia.

J W Hadfield.   

Abstract

Rifampicin occasionally causes thrombocytopenia when given as part of an intermittent regimen. A case is reported of severe thrombocytopenia developing after one dose of rifampicin, following a 4-month gap in daily therapy. The literature on rifampicin-induced thrombocytopenia is reviewed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7383953      PMCID: PMC2425983          DOI: 10.1136/pgmj.56.651.59

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment.

Authors:  L Di Berardino; G Perna; L G Silvestri
Journal:  Am Rev Respir Dis       Date:  1976-12

Review 2.  Adverse reactions to rifampicin in antituberculosis regimens.

Authors:  D J Girling
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

3.  Sensitivity to rifampicin: incidence, mechanism, and prevention.

Authors:  J C Pujet; J C Homberg; G Decroix
Journal:  Br Med J       Date:  1974-05-25

4.  Rifampicin and thrombocytopenia.

Authors:  G C Ferguson
Journal:  Br Med J       Date:  1971-09-11
  4 in total
  4 in total

Review 1.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Control of meningococcal disease.

Authors:  S Travis
Journal:  BMJ       Date:  1989-04-15

3.  Thrombocytopenia due to rifampicin.

Authors:  Ramakant Dixit; Jacob George; Arun Kumar Sharma
Journal:  Lung India       Date:  2012-01

4.  Isoniazid-induced Immune Thrombocytopenia.

Authors:  Gaku Kuwabara; Kumiyo Tazoe; Waki Imoto; Kazushi Yamairi; Wataru Shibata; Kazuhiro Oshima; Koichi Yamada; Yasuhiro Takagi; Satoshi Shiraishi; Masayuki Hino; Tomoya Kawaguchi; Hiroshi Kakeya
Journal:  Intern Med       Date:  2021-05-29       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.